J.w. Cole Advisors »

Plus Therapeutics shares owned by J.w. Cole Advisors

Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by J.w. Cole Advisors from 13F filings

Historical chart of J.w. Cole Advisors investment in Plus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Plus Therapeutics held by J.w. Cole Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Plus Therapeutics by J.w. Cole Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.1k 10k 0.51

More positions owned by J.w. Cole Advisors

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)
Ishares Tr Core Div Grwth (DGRO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr S&p 500 Grwt Etf (IVW)
JPMorgan Chase & Co. (JPM)

View all positions for J.w. Cole Advisors

Top funds holding Plus Therapeutics

Vanguard Group
BlackRock
Geode Capital Management
Jane Street
UBS Group
Virtu Financial
State Street Corporation
Northern Trust
XTX Topco
Two Sigma Securities
Dagco
Kestra Advisory Services
Ashton Thomas Private Wealth
HighTower Advisors
Cambridge Investment Research Advisors

View all funds holding Plus Therapeutics